Ladenburg Thalmann Financial Services’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
GWM
HF
BG
TRCT
SBIA
SW
CIA
Ladenburg Thalmann Financial Services's BIB Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services increased its ProShares Ultra NASDAQ Biotechnology (BIB) stake by 500% in Q4 2019, buying an estimated $26.7K and bringing the position to 600 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.
Ladenburg Thalmann Financial Services first reported a position in BIB in Q1 2015 and has held it in 20 quarters since. The position peaked at $81K in Q2 2015. 26 funds tracked by Wall St. Rank hold BIB as of Q4 2019.
- Ladenburg Thalmann Financial Services held 600 shares of ProShares Ultra NASDAQ Biotechnology worth $37K as of Q4 2019.
- Ladenburg Thalmann Financial Services bought 500 ProShares Ultra NASDAQ Biotechnology shares in Q4 2019, an estimated $26.7K.
- ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3725 holding.
- Ladenburg Thalmann Financial Services first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2015 and has held it in 20 quarters since.
- Ladenburg Thalmann Financial Services's ProShares Ultra NASDAQ Biotechnology position peaked at $81K in Q2 2015.
- 26 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.